VRX

Allergan board unanimously rejects Valeant bid

moreView todays social media effects on VRXView the latest stocks trending across Twitter. Click to view dashboardSee who Valeant is hiring next, click here to view […]

An Inside Look at Finding Outsider CEOs

moreView todays social media effects on VRXView the latest stocks trending across Twitter. Click to view dashboardSee who Valeant is hiring next, click here to view […]

Allergan poised to reject Valeant’s $46bn bid

[at Financial Times] – Allergan, the maker of Botox, is preparing to reject the $46bn offer by rival Valeant Pharmaceuticals, setting up the prospect of a hostile takeover battle at the top of the US drug-making industry. Allergan, … moreView todays social media effects on VRXView the latest stocks trending across Twitter. Click to view dashboardSee who Valeant is hiring […]

[$$] Valeant Steps Up Hostile Takeover Campaign Against Allergan

[at The Wall Street Journal] – Valeant Pharmaceuticals, escalating its public campaign to acquire Botox-maker Allergan, threatened to remove members of Allergan’s board of directors if necessary through a special meeting…. moreView todays social media effects on VRXView the latest stocks trending across Twitter. Click to view dashboardSee who Valeant is hiring next, click here to view […]

Valeant Pharmaceuticals International’s (VRX) CEO Michael Pearson on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – J. Michael Pearson Thank you, Laurie. Good morning, everyone, and thank you for joining us. Today’s call will be relatively short, as we just recently provided a very comprehensive overview of the Valeant … moreView todays social media effects on VRXView the latest stocks trending across Twitter. Click to view dashboardSee who Valeant is hiring next, […]